For an asymptomatic adult aged ≥40 years without known atherosclerotic disease, how should I interpret and manage different coronary artery calcium (CAC) scores?

Coronary Artery Calcium Score Interpretation and Management

For asymptomatic adults ≥40 years without known atherosclerotic disease, use CAC scoring to guide statin therapy with clear thresholds: CAC = 0 allows you to withhold statins (unless diabetes, family history of premature CHD, or smoking present), CAC 1-99 favors statin therapy especially after age 55, and CAC ≥100 or ≥75th percentile mandates statin initiation. 1

Risk-Based Approach to CAC Testing

CAC scoring is most valuable when treatment decisions are uncertain, particularly in:

• Intermediate risk (7.5-20% 10-year ASCVD risk) - primary indication 1
• Borderline risk (5-7.5% 10-year ASCVD risk) - selective use when risk-enhancing factors present 1
• Low risk with concerning features - strong family history, diabetes <50 years with <10 years duration and no other risk factors 1

Recent 2026 data using the PREVENT equations supports selective CAC use in those with borderline to intermediate risk (3% to <10% 10-year risk), where it provides greatest clinical value for treatment decisions 2, 3.

Treatment Thresholds by CAC Score

CAC = 0 (Zero Calcium)

• Downgrade risk and withhold statin therapy 1
• Critical exceptions - still consider statins if:
  • Diabetes present
  • Family history of premature CHD
  • Active cigarette smoking 1
• Event rates extremely low: 1.2-2.7 per 1,000 person-years even in higher risk groups 3
• Repeat CAC in 3-7 years depending on age and risk factors 1, 4
• 10-year ASCVD event rate only 1.5-3.0% 4

Important caveat: Among those already meeting guideline-based treatment thresholds, elevated ASCVD event rates persist even with CAC = 0, suggesting CAC zero should not routinely override established treatment indications 3.

CAC = 1-99 (Mild Calcium)

• Favor statin therapy, especially after age 55 1
• Modest risk reclassification warranted 4
• 10-year ASCVD rates by age group: 3.8% (ages 45-54), 6.5% (ages 55-64), 8.3% (ages 65-74) 4
• Event rates: 3.9% in borderline risk, 5.2% in intermediate risk groups 2
• If deferring treatment, reconsider in 3-5 years unless active smoking, diabetes, chronic inflammatory conditions, or family history of premature CAD present 4

CAC ≥100 or ≥75th Percentile

• Initiate statin therapy - this is a firm recommendation 1
• Event rates ≥20 per 1,000 person-years across dyslipidemia spectrum 4
• Approximates secondary prevention population risk 4
• SCCT specialty guideline: High-intensity statin + aspirin 81 mg 1
• Number needed to treat (NNT) = 28-30 to prevent one ASCVD event over 10 years 4

CAC 100-299

• Event rate 7.4% in borderline risk patients 2
• High-intensity statin recommended

CAC ≥300

• Event rate 14.3% in borderline risk patients 2
• Very high risk requiring aggressive therapy

Age-Specific Considerations

Younger patients (ages 30-49):

• 34% have CAC >0 4
• 7.2% have CAC >100 with 10-fold higher CAD mortality 4
• Consider CAC in select younger patients with risk factors (smoking, hyperglycemia, hyperlipidemia, hypertension) 4
• May identify candidates for early intervention despite low calculated 10-year risk 4

Clinical Outcomes Data

The prognostic value of CAC is robust:

• CAC >0 vs CAC = 0 in asymptomatic patients: 4.05-fold increased risk of MACE 5
• All-cause mortality: 3.23-fold higher with CAC >0 5
• CAC provides incremental value beyond traditional risk factors with consistent graded association 6
• More strongly predictive of coronary events than stroke - it's a coronary-specific marker 6

Common Pitfalls to Avoid

1. Don't use CAC in symptomatic patients for diagnosis: 7-38% of symptomatic patients with CAC = 0 have obstructive CAD because noncalcified plaque isn't detected 4. CAC is for risk stratification in asymptomatic individuals only.

2. Don't ignore high-risk features with CAC = 0: Diabetes, family history of premature CHD, and active smoking override the reassurance of zero calcium 1

3. Don't forget to reassess: CAC = 0 has a "variable expiration date" - younger patients and those with risk factors need reevaluation in 3-5 years 4

4. Don't routinely order downstream testing: No conclusive evidence supports routine stress testing or invasive evaluation in asymptomatic patients with elevated CAC unless functional capacity cannot be reliably estimated 4

5. Recognize CAC's greatest value: It provides most clinical utility when statin treatment decisions are uncertain, particularly in borderline to intermediate risk populations 3. In those already meeting treatment thresholds, CAC should not generally be used to withhold indicated therapy 3.

Patient Motivation and Adherence

CAC visualization motivates patients: those with detectable calcium show better blood pressure control, lipid levels, and Framingham risk scores without increasing downstream testing 4. CAC >0 associates with higher likelihood of starting and continuing preventive therapy and lifestyle modification 4.